Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology

European Journal of Cardio-thoracic Surgery

Volumn 46, Issue 4, 2014, Pages 637-642

  Tsutani, Yasuhiro ^a   Miyata, Yoshihiro ^a   Nakayama, Haruhiko ^b   Okumura, Sakae ^c   Adachi, Shuji ^d   Yoshimura, Masahiro ^d   Okada, Morihito ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

^d HYOGO CANCER CENTER   (Japan)

Author keywords

Computed tomography; Lung cancer surgery; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG RESECTION; LUNG SEGMENTECTOMY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PET-CT SCANNER; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SOLID TUMOR; ADENOCARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; LUNG NEOPLASMS; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIOGRAPHY; SCINTISCANNING; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84899926301     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt645     Document Type: Article

References (22)

1. Jensik RJ, Faber LP, Milloy FJ, Monson DO. Segmental resection for lung carcinoma. A fifteen-year experience. J Thorac Cardiovasc Surg 1973;66: 563-72.
2. Ginsberg RH, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-23.
3. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 2006;132:769-75.
4. Okada M, Tsutani Y, Ikeda T, Misumi K, Matsumoto K, Yoshimura M et al. Radical hybrid video-assisted thoracic segmentectomy: long-term results of minimally invasive anatomical sublobar resection for treating lung cancer. Interact CardioVasc Thorac Surg 2012;14:5-11.
5. Whitson BA, Groth SS, Andrade RS, Maddaus MA, Habermann EB, D'Cunha J. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis. Ann Thorac Surg 2011;92:1943-50.
6. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M et al. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study. J Thorac Cardiovasc Surg 2013;146:358-64.
7. Kodama K, Higashiyama M, Yokouchi H, Takami K, Kuriyama K, Mano M et al. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 2001;33:17-25.
8. Asamura H, Hishida T, Suzuki K, Koike T, Nakamura K, Kusumoto M et al. Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg 2013;146:24-30.
9. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M et al. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy. Chest 2014;145:66-71.
10. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R et al. International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of Malignant Tumours. J Thorac Oncol 2007;2:706-14.
11. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshiura M et al. Prognostic significance of using solid versus whole tumor size on highresolution computed tomography for predicting the pathological malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study. J Thorac Cardiovasc Surg 2012;143:607-12.
12. Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med 2006;47:885-95.
13. Mawlawi O, Podoloff DA, Kohlmyer S, Williams JJ, Stearns CW, Culp RF et al. Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. J NuclMed 2004;45:1734-42.
14. Okada M, Nakayama H, Okumura S, Daisaki H, Adachi S, Yoshimura M et al. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. J Thorac Cardiovasc Surg 2011;141:1384-91.
15. Inoue M, Minami M, Sawabata N, Utsumi T, Kadota Y, Shigemura N et al. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer. Eur J Cardiovasc Surg 2010;89:1312-9.
16. Hattori A, Suzuki K, Matsunaga T, Fukui M, Kitamura Y, Miyasaka Y et al. Is limited resection appropriate for radiologically 'solid' tumors in small lung cancers? Ann Thorac Surg 2012;94:212-5.
17. Tsutani Y, Miyata Y, Yamanaka T, Nakayama H, Okumura S, Adachi S et al. Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings. J Thorac Cardiovasc Surg 2013;146:17-23.
18. Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg 2006;81:413-9.
19. Tsutani Y, Miyata Y, Misumi K, Ikeda T, Mimura T, Hihara J et al. Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung. Jpn J Clin Oncol 2011;41:890-6.
20. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M et al. Prediction of pathological node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. J Thorac Cardiovasc Surg 2012;144:1365-71.
21. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M et al. Solid tumor size on high-resolution computed tomography and maximum standardized uptake value on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma. Ann Oncol 2013;24:2376-81.
22. Nakamura K, Saji H, Nakajima R, Okada M, Asamura H, Shibata T et al. A phase III randomized trial of lobectomy versus limited resection for smallsized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol 2010;40:271-4.